Loading organizations...
Founded in 2000 and based in Seoul, GN Tech Venture Capital is a South Korean firm whose historical portfolio includes recognizable enterprises like Kakao, Cafe24, Market Kurly, and Musinsa. The organization invests in early-stage to scale-up startups across various industries, specializing primarily in secondary investments, biotechnology, and IT platform services. Operating as a subsidiary of the KOSDAQ-listed KookSoonDang Brewery, the firm manages capital from institutional sources like the National Pension Fund and the Korea Growth Fund. With a dedicated team of eleven to twenty employees, the business manages accumulated operating funds of KRW 436 billion, representing approximately 300 million dollars in total assets under management. Leveraging over twenty-five years of industry experience, the venture capital firm has executed more than two hundred investments and supported around 290 portfolio companies to help them grow.
G.N. Tech Venture Capital has 4 tracked investments across 3 companies. The latest tracked deal is $19.0M Series B in Hummingbird Bioscience in December 2019.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 5, 2019 | Hummingbird Bioscience | $19.0M Series B | G.n. Tech Venture Capital, Mirae Asset Venture Investment | Davalue Giltedge, Delian Capital, HB Investment, Heritas Capital, Kiwoom Investment Shinhan Capital, Mirae Asset Capital, Seeds Capital, Wooshin Venture Investment |
| Mar 7, 2017 | ImmunoMet Therapeutics | $5.0M Series B | — | Sungwuk KIM, Intervest, Mirae Asset Venture Investment, NHN Ventures, SL Investment |
| Dec 8, 2016 | Eutilex | $18.1M Series A | — | DS Asset Management, Kolon Investment, SNU BIO Angel |
| Mar 8, 2016 | ImmunoMet Therapeutics | $5.2M Series A | JAE Joon KIM | AJU Tech, Metavest Capital |
